This article is a correction to:
Approach for delabeling beta-lactam allergy in children
R. Sáenz de Santa María1,2
G. Bogas1,2
M. Labella1,2
A. Ariza2
M. Salas1,2
I. Doña1,2,†
M. J. Torres1,2,3,4*†
- 1Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain
- 2Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Civil, Málaga, Spain
- 3Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Parque Tecnológico de Andalucía, Málaga, Spain
- 4Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain
A Corrigendum on
Approach for delabeling beta-lactam allergy in children
By Sáenz de Santa María R, Bogas G, Labella M, Ariza A, Salas M, Doña I, Torres MJ. (2023). Front Allergy. 4:1298335. doi: 10.3389/falgy.2023.1298335
In the published article, there was an error in the Funding statement. The following was incorrectly written: ‘The present study has been supported by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): PI21/00329, and Redes de Investigación Cooperativa Orientadas al Resultado en Salud: Enferemedades Inflamatorias (RD21/0002/0008).’
This has been replaced by ‘The present study has been funded by Instituto de Salud Carlos III through the project “PI21/00329” and co-funded by the European Union.’
The full, correct Funding statement appears below.
Funding
GB holds a contract from “Juan Rodes” program (JR18/00054) from the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness [grants co-funded by European Social Fund (ESF)]. AA holds a Senior Postdoctoral Contract (RH-0099–2020) from Andalusian Regional Ministry of Health [cofunded by European Social Fund (ESF): “Andalucía se mueve con Europa”]. The present study has been funded by Instituto de Salud Carlos III through the project “PI21/00329” and co-funded by the European Union.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: anaphylaxis, beta-lactam, children, drug provocation test, maculopapular exanthema, skin test, urticaria
Citation: Sáenz de Santa María R, Bogas G, Labella M, Ariza A, Salas M, Doña I and Torres MJ (2024) Corrigendum: Approach for delabeling beta-lactam allergy in children. Front. Allergy 4:1361973. doi: 10.3389/falgy.2023.1361973
Received: 27 December 2023; Accepted: 28 December 2023;
Published: 12 January 2024.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
© 2024 Sáenz de Santa María, Bogas, Labella, Ariza, Salas, Doña and Torres. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: M. J. Torres mjtorresj@uma.es
†These authors have contributed equally to this work